山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (6): 5-8.doi: 10.6040/j.issn.1673-3770.1.2017.039

• 甲状腺癌的规范化诊断与治疗·专题笔谈 • 上一篇    下一篇

美国癌症联合委员会第8版甲状腺癌TNM分期解读

邱杰1,孙莎莎2,孙彦1   

  1. 1.青岛大学附属医院耳鼻咽喉头颈外科, 山东 青岛 266003;
    2.潍坊医学院研究生院, 山东 潍坊 261053
  • 收稿日期:2017-10-09 出版日期:2017-12-16 发布日期:2017-12-16
  • 通讯作者: 孙彦. E-mail:sunyanent@163.com

Interpretation of the eighth edition of thyroid cancer tumor-node-metastasis staging by American Joint Committee on Cancer.

QIU Jie1, SUN Shasha2, SUN Yan1   

  1. 1. Department of Otolaryngology &Head and Neck Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China;2. Department of Postgraduate, Weifang Medical College, Weifang 261053, Shandong, China
  • Received:2017-10-09 Online:2017-12-16 Published:2017-12-16

PDF (PC)

2665

被引次数

4

摘要： TNM分期系统是目前国际上最为通用的肿瘤分期系统,确定T、N、M后就可以得出相应的总的分期,即Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期。美国癌症联合委员会(AJCC)制定的肿瘤TNM分期标准已被广泛认可和应用。近期AJCC发布的第8版肿瘤TNM分期将于2018年1月1日正式在全球实施。对AJCC第8版中甲状腺癌TNM分期标准的内容及其相对于第7版的改动进行解读。

关键词: 美国癌症联合委员会, TNM分期, 甲状腺癌

Abstract: The tumor-node-metastasis(TNM)staging system is currently the most common tumor staging system worldwide. After examining tumors, nodes, and metastases(per TNM staging), the corresponding general stages can be determined, namely, stages Ⅰ, Ⅱ, Ⅲ, and Ⅳ. The American Joint Committee on Cancer(AJCC)has developed a TNM staging standard that has been widely recognized and applied. The eighth edition of the tumor TNM staging system released by AJCC will be implemented globally by January 1, 2018. In this paper, the content of the thyroid cancer TNM staging standard in the eighth edition of AJCC and the changes relative to the seventh edition will be interpreted in detail.

Key words: Thyroid cancer, TNM staging, American Joint Committee on Cancer

中图分类号: 

  • R736.1
[1] 刘荫华, 姚宏伟, 周斌,等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J].中国实用外科杂志, 2017, 37(1):6-9. LIU Yinhua, YAO Hongwei, ZHOU Bin, et al. Updates and interpretations of AJCC cancer staging manual 8th edition for colorectal carcinoma[J].Chin J Prac Surg, 2017, 37(1):6-9.
[2] 孙彦, 王琪. 2002年AJCC甲状腺癌分期方案[J].国际耳鼻咽喉头颈外科杂志,2004, 28(6):385-386.
[3] 孙威, 贺亮, 张浩. 美国癌症联合委员会甲状腺癌分期系统(第8版)更新解读[J].中国实用外科杂志, 2017, 37(3):255-258. SUN Wei, HE Liang, ZHANG Hao. Interpretations on the updates of American Joint Committee on cancer staging system(8th edition)for thyroid cancer[J]. Chin J Prac Surg, 2017, 37(3):255-258.
[4] Kim M, Kim YN, Kim WG, et al. Optimal cutoff age in the TNM staging system of differentiated thyroid cancer: is 55 years better than 45 years?[J].Clin Endocrinol, 2017, 86(3):438-443.
[5] Tuttle RM, Haugen B, Perrier ND. The updated AJCC/TNM staging system for differentiated and anaplastic thyroid cancer(8th edition): what changed and why?[J]. Thyroid, 2017, 27(6):751-756.
[6] Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474.
[7] Edge SB. AJCC cancer staging manual[J]. Jama, 2010, 304(15):1726-1727.
[8] Beahrs OH, Myers MH. American Joint Committee on cancer manual for staging of cancer[M]. 2nd ed. Philadelphia: JB Lippincott, 1983.
[9] Nixon IJ, Wang LY, Migliacci JC, et al. An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer.[J]. Thyroid, 2016, 26(3):373-380.
[10] Kim M, Kim WG, Oh HS, et al. Comparison of the 7th and 8th editions of the AJCC/UICC TNM staging system for differentiated thyroid cancer[J]. Thyroid, 2017, 27(9):1149.
[11] Kim TH, Kim YN, Kim HI, et al. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma[J]. Oral Oncol, 2017, 71:81-86.
[12] Beahrs O, Carr DT, Rubin P. American Joint Committee for cancer staging and end results reporting[M]. Manual for Staging of Cancer. Philadelphia, PA: J B Lippincott Co., 1977.
[13] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474.
[14] Wells SA Jr, Asa SL, Dralle H, et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610.
[15] Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: A review[J]. Cancer, 2016, 122(3):358-366.
[16] Boostrom SY, Grant CS, Thompson GB, et al. Need for a revised staging consensus in medullary thyroid carcinoma.[J]. Arch Surg, 2009, 144(7):663-669.
[17] Tuttle RM, Ganly I. Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging[J]. Oral Oncol, 2013, 49(7):695-701.
[18] Yang JH, Lindsey SC, Camacho CP, et al. Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer[J]. Clin Endocrinol, 2016, 83(6):938-942.
[19] Wang W, Sun XW, Li CF, et al. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients[J]. Ann Surg Oncol, 2011, 18(4):1060-1067.
[20] Kim TY, Kim WG, Kim WB, et al. Current status and future perspectives in differentiated thyroid cancer[J]. Endocrinol Metab, 2014, 29(3):217-225.
[1] 张中华,王辉,王俊鑫,张美玲,张建,张恩东,潘新良. 腋窝入路腔镜手术和传统颈部开放手术治疗T1甲状腺癌的安全性和有效性对比研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 161-167.
[2] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[3] 王安洋,李超友,薛刚,吴靖芳. 肠道菌群与甲状腺疾病的关系[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 132-139.
[4] 张轶轶,薛刚,金春亭. 外泌体在甲状腺癌的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 131-135.
[5] 潘新良. 加强甲状腺结节及恶性肿瘤的规范治疗[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 1-12.
[6] 陈海兵, 卫亚楠, 许晓泉, 陈曦. 基于XGBoost人工智能结合CT构建甲状腺癌颈部淋巴结转移预测模型[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 40-45.
[7] 邓迪,刘均,李林珂,王吉,刘吉峰,吕丹,王海洋,甘卫刚,王君,李波,陈飞. 皮瓣二期重建策略应用于气管非环周缺损修复重建[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 52-57.
[8] 房忠菊, 张永侠, 赵建东, 纵亮, 翟性友, 李新建, 彭新, 任楠, 陈立伟, 刘明波. 甲状腺癌颈清扫术后乳糜漏的综合治疗[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 64-68.
[9] 吕静荣,陈淳,马衍,谢晋. 儿童分化型甲状腺癌的临床特征及危险因素分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 88-94.
[10] 冯云,钟志明,陈国庆. 纳米碳在甲状腺乳头状癌隐匿性侧颈转移淋巴结清扫术中的临床应用价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 101-106.
[11] 马驰,郑桂彬,孙海清,吴国长,郭雅文,孔杨,宋西成,郑海涛. 加速康复外科理念应用于甲状腺癌手术100例[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 107-110.
[12] 王佳说,郭星,阎艾慧. 甲状腺乳头状癌颈淋巴结转移形成巨大囊性变的诊断总结[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 111-113.
[13] 高晓倩,姜震,耿琛琛,刘大昱,李荔. 术前超声评估分化型甲状腺癌颈部淋巴结转移[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 135-139.
[14] 徐书杭, 李春睿, 刘超. 儿童甲状腺癌的规范化诊治[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 12-15.
[15] 普布次仁,刘吉峰,巴罗. 甲状腺癌与外周静脉血炎性相关指标[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 21-24.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发